Exponent CEO exercises options for 12,665 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Exponent Inc. reports that Chief Executive Officer Catherine Corrigan exercised options to acquire 12,665 shares of common stock on July 28, 2026 at an exercise price of $37.45 per share, converting a Non-Qualified Stock Option scheduled to expire on February 15, 2028.
Following the exercise, Corrigan directly holds 128,436 shares of Exponent common stock.
Insider Trade Summary
12,665 shares exercised/converted
Exercise
2 txns
Insider
Corrigan Catherine
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F2, F1 | 12,665 | -- | -- |
| Exercise | Common Stock | 12,665 | $37.45 | $474K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 12,665 contracts (Direct);
Common Stock — 128,436 shares (Direct)
Footnotes (2)
- F1. The stock option becomes exercisable in four equal annual installments.
- F2. Not applicable.
Key Figures
Options Exercised: 12,665 shares
Exercise Price: $37.45 per share
Shares Held After Transaction: 128,436 shares
+1 more
4 metrics
Options Exercised
12,665 shares
Non-Qualified Stock Option converted to common stock on July 28, 2026
Exercise Price
$37.45 per share
Exercise price of the Non-Qualified Stock Option
Shares Held After Transaction
128,436 shares
Directly held Exponent common stock following the option exercise
Option Expiration Date
February 15, 2028
Original expiration date of the exercised Non-Qualified Stock Option
Key Terms
Non-Qualified Stock Option, derivative security, Common Stock
3 terms
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (right to buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did EXPO CEO Catherine Corrigan report?
Catherine Corrigan exercised stock options to acquire 12,665 Exponent (EXPO) common shares. The options were Non-Qualified Stock Options, converted on July 28, 2026, at an exercise price of $37.45 per share, increasing her directly held common stock position.
What was the exercise price of Catherine Corrigan’s EXPO stock options?
The exercised Non-Qualified Stock Options had an exercise price of $37.45 per Exponent (EXPO) share. Corrigan converted options covering 12,665 underlying shares into common stock at this price on July 28, 2026, and the original option was correspondingly disposed of.
Were Catherine Corrigan’s EXPO transactions under a Rule 10b5-1 plan?
The Form 4 indicates the transactions were not made pursuant to a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is explicitly unchecked, so these exercises are reported as discretionary rather than pre-planned trades.
What were the terms of the EXPO options exercised by Catherine Corrigan?
Corrigan exercised a Non-Qualified Stock Option for 12,665 Exponent (EXPO) shares at $37.45 per share. A footnote states the option became exercisable in four equal annual installments and was scheduled to expire on February 15, 2028, before this full exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates